Earnings Call Summary | TECSYS INC(TCYSF.US) Q2 2025 Earnings Conference
Earnings Call Summary | TECSYS INC(TCYSF.US) Q2 2025 Earnings Conference
Net profit for the quarter was $758,000, a turnaround from a net loss of $340,000 in the corresponding quarter of the previous year.The following is a summary of the Tecsys Inc. (TCYSF) Q2 2025 Earnings Call Transcript:
以下是Tecsys Inc.（TCYSF）2025年第二季度業績會的摘要：
Financial Performance:
財務表現：
Tecsys Inc. reported a significant year-over-year SaaS revenue growth of 34%, reaching $16.1 million in Q2.
Gross margin improved to 48%, up from 44% in the same period last year, primarily due to increasing SaaS margins and Professional Services strength.
Net profit for the quarter was $758,000, a turnaround from a net loss of $340,000 in the corresponding quarter of the previous year.
Adjusted EBITDA was $2.9 million in Q2, compared to $1.0 million in Q2 of the previous year.
Tecsys Inc.報告了34%的營業收入同比增長，在第二季度達到了1610萬美金。
毛利率改善至48%，高於去年同期的44%，主要得益於saas概念毛利率的提升和專業服務的強勁表現。
本季度淨利潤爲758,000美金，扭轉了去年同期340,000美金的淨虧損。
調整後的EBITDA在第二季度爲290萬美金，而去年第二季度爲100萬美金。
Business Progress:
業務進展：
Achieved annual recurring revenue of $100 million and SaaS RPO surpassing $200 million, indicating robust business health and solid foundation.
Launched version 24.2 of the Elite product, enhancing data utilization for client solutions.
Extended market reach and presence through partnerships with firms like Locus Robotics and inclusion in the Shopify App Store.
Conducted successful industry-specific engagements, such as the Pharmacy Summit, and secured significant market recognitions like the 2024 WMS Technology Value Matrix.
實現年常規營業收入10000萬，saas概念RPO超過20000萬，表明業務健康強勁，基礎穩固。
推出Elite產品的24.2版本，以提高客戶解決方案的數據利用率。
通過與Locus Robotics等公司的合作關係以及在shopify應用商店中的參與，擴大市場覆蓋和影響力。
開展了成功的行業特定活動，例如藥店峯會，並獲得了2024年WMS科技價值矩陣等重要市場認可。
Opportunities:
機會：
Continued expansion in healthcare and pharmacy sectors, with a strong pipeline indicating high buyer intent and potential for substantial growth.
Strategic partnership approach aimed at enhancing scalability and tapping into new market opportunities globally.
Introduction of innovative SaaS solutions targeting specific use cases to foster essential business operations.
在醫療保健和藥品行業持續擴展，強大的客戶意向表明有巨大的增長潛力。
戰略合作伙伴關係旨在提高可擴展性，發掘全球新的市場機會。
推出創新的saas概念解決方案，以針對特定用例促進關鍵業務運營。
Risks:
風險：
Potential disruptions in general distribution markets due to evolving tariffs and geopolitical shifts may impact sub-segments of the business.
由於關稅和地緣政治變動，整體分銷市場可能出現潛在干擾，這可能會影響業務的子部門。
More details: TECSYS INC IR
更多詳情：TECSYS INC IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
